Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1986 Sep;30(3):505–507. doi: 10.1128/aac.30.3.505

Aztreonam concentrations in human tissues obtained during thoracic and gynecologic surgery.

T R Beam Jr, R P Galask, L T Friedhoff, T B Platt, M A Leitz
PMCID: PMC180589  PMID: 3777914

Abstract

The concentrations of aztreonam in human tissues obtained during surgery were measured after a single 2-g intravenous dose. The average concentration in the skeletal muscle, atrial appendage, lung, sternum, pericardial fluid, endometrium, myometrium, fallopian tube, and ovary varied from 3 to 33 micrograms/g (or microgram/ml). These concentrations significantly exceed the MIC for 90% of strains for most members of the family Enterobacteriaceae.

Full text

PDF
506

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bechard D. L., Hawkins S. S., Dhruv R., Friedhoff L. T. Penetration of aztreonam into human bronchial secretions. Antimicrob Agents Chemother. 1985 Feb;27(2):263–264. doi: 10.1128/aac.27.2.263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Daschner F. D., Petersen E. E., Frank U., Hornig D. Penetration of cefmenoxime into serum, gynecologic tissues, and heart valves. Am J Med. 1984 Dec 21;77(6A):4–6. [PubMed] [Google Scholar]
  3. Duma R. J., Berry A. J., Smith S. M., Baggett J. W., Swabb E. A., Platt T. B. Penetration of aztreonam into cerebrospinal fluid of patients with and without inflamed meninges. Antimicrob Agents Chemother. 1984 Nov;26(5):730–733. doi: 10.1128/aac.26.5.730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gerig J. S., Bolton N. D., Swabb E. A., Scheld W. M., Bolton W. K. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics. Kidney Int. 1984 Sep;26(3):308–318. doi: 10.1038/ki.1984.174. [DOI] [PubMed] [Google Scholar]
  5. Greenman R. L., Arcey S. M., Dickinson G. M., Mokhbat J. E., Sabath L. D., Platt T. B., Friedhoff L. T. Penetration of aztreonam into human cerebrospinal fluid in the presence of meningeal inflammation. J Antimicrob Chemother. 1985 May;15(5):637–640. doi: 10.1093/jac/15.5.637. [DOI] [PubMed] [Google Scholar]
  6. Henry S. A., Bendush C. B. Aztreonam: worldwide overview of the treatment of patients with gram-negative infections. Am J Med. 1985 Feb 8;78(2A):57–64. doi: 10.1016/0002-9343(85)90206-2. [DOI] [PubMed] [Google Scholar]
  7. Just H. M., Bassler M., Frank U., Spillner G., Schlosser V., Daschner F. Penetration of cefotaxime into heart valves, subcutaneous and muscle tissue of patients undergoing open-heart surgery. J Antimicrob Chemother. 1984 Oct;14(4):431–434. doi: 10.1093/jac/14.4.431. [DOI] [PubMed] [Google Scholar]
  8. Madsen P. O., Dhruv R., Friedhoff L. T. Aztreonam concentrations in human prostatic tissue. Antimicrob Agents Chemother. 1984 Jul;26(1):20–21. doi: 10.1128/aac.26.1.20. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Martinez O. V., Levi J. U., Devlin R. G. Biliary excretion of aztreonam in patients with biliary tract disease. Antimicrob Agents Chemother. 1984 Mar;25(3):358–361. doi: 10.1128/aac.25.3.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Nightingale C. H., Quintiliani R., Dudley M. N., Gough P., Hickingbotham M., Jordan N. S., Rose D., Toscani M. Tissue penetration and half-life of cefonicid. Rev Infect Dis. 1984 Nov-Dec;6 (Suppl 4):S821–S828. doi: 10.1093/clinids/6.supplement_4.s821. [DOI] [PubMed] [Google Scholar]
  11. Pilkiewicz F. G., Remsburg B. J., Fisher S. M., Sykes R. B. High-pressure liquid chromatographic analysis of aztreonam in sera and urine. Antimicrob Agents Chemother. 1983 Jun;23(6):852–856. doi: 10.1128/aac.23.6.852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rettenmaier M. A., Miller R. D., Berman M. L., DiSaia P. J. Pharmacokinetic study of moxalactam in patients undergoing gynecologic operations. Am J Obstet Gynecol. 1984 Dec 1;150(7):882–884. doi: 10.1016/0002-9378(84)90467-8. [DOI] [PubMed] [Google Scholar]
  13. Richards D. M., Brogden R. N. Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs. 1985 Feb;29(2):105–161. doi: 10.2165/00003495-198529020-00002. [DOI] [PubMed] [Google Scholar]
  14. Swabb E. A., Sugerman A. A., Platt T. B., Pilkiewicz F. G., Frantz M. Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects. Antimicrob Agents Chemother. 1982 Jun;21(6):944–949. doi: 10.1128/aac.21.6.944. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sykes R. B., Bonner D. P., Bush K., Georgopapadakou N. H. Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrob Agents Chemother. 1982 Jan;21(1):85–92. doi: 10.1128/aac.21.1.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Winslade N. E., Smith I. L., Simons G. W., Swanson D. J., Vigano A., Wels P. B., Schentag J. J. Pharmacokinetics and extravascular penetration of aztreonam in patients with abdominal sepsis. Rev Infect Dis. 1985 Nov-Dec;7 (Suppl 4):S716–S723. doi: 10.1093/clinids/7.supplement_4.s716. [DOI] [PubMed] [Google Scholar]
  17. Wise R., Dyas A., Hegarty A., Andrews J. M. Pharmacokinetics and tissue penetration of azthreonam. Antimicrob Agents Chemother. 1982 Dec;22(6):969–971. doi: 10.1128/aac.22.6.969. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES